Both in Pharmaceuticals
XBiotech vs Clene
Over the past year XBIT returned −16.7% and CLNN returned −57.0%; their daily moves had a correlation of -0.05.
XBIT −16.7% CLNN −57.0%Growth of $1, one year, split-adjusted
| Metric | XBIT | CLNN |
|---|---|---|
| Price | $1.99 | $4.03 |
| Market cap | $60.7M | $57.3M |
| Today | +7.57% | +1.51% |
| 1 month | −8.7% | −1.7% |
| 6 months | −21.0% | −30.5% |
| Year to date | −16.7% | −31.3% |
| 1 year | −22.6% | −52.6% |
| Revenue growth (YoY) | — | +233.3% |
| Gross margin | — | 60.0% |
| Net margin | — | −14915.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 290.8× |
| Net cash | $109.5M | -$9.1M |
| Dividend yield | — | — |
| Volatility (60d) | 34.2% | 81.6% |
| Short % of float | 1.8% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).